Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Khalid AlMuti"'
Autor:
Wasim S. El Nekidy PharmD, Khalid Almuti MD, Hazem ElRefaei PharmD, Bassam Atallah PharmD, Lana M. Mohammad RPh, Wael AlMahmeed MD, Mohamed Badr MD, Khaled Abdallah MD, Fadi Hamed MD, Jihad Mallat MD
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics, Vol 27 (2022)
Background: Several reports linked the use of repurposed drugs such as hydroxychloroquine (HCQ), azithromycin, lopinavir/ritonavir, and favipiravir with QT interval prolongation in patients with SARS-CoV2 infection. Little is known about the risk fac
Externí odkaz:
https://doaj.org/article/4fac1f694f3d4ce7882706c10f8b41e4
Autor:
Daniel TT Chong, Felicita Andreotti, Peter Verhamme, Jamshed J Dalal, Noppacharn Uaprasert, Chun-Chieh Wang, Young Keun On, Yi-Heng Li, Jun Jiang, Koji Hasegawa, Khalid Almuti, Rong Bai, Sidney TH Lo, Rungroj Krittayaphong, Lai Heng Lee, David KL Quek, Sofian Johar, Swee-Chong Seow, Christopher J Hammett, Jack WC Tan
Publikováno v:
European Cardiology Review, Vol 16, Iss , Pp - (2021)
The disease burden of AF is greater in Asia-Pacific than other areas of the world. Direct oral anticoagulants (DOACs) have emerged as effective alternatives to vitamin K antagonists (VKA) for preventing thromboembolic events in patients with AF. The
Externí odkaz:
https://doaj.org/article/49c5064400184fe5a7cde8efc907810e
Autor:
Wasim S. El Nekidy, Khalid Almuti, Hazem ElRefaei, Bassam Atallah, Lana M. Mohammad, Wael AlMahmeed, Mohamed Badr, Khaled Abdallah, Fadi Hamed, Jihad Mallat
Background: Several reports linked the use of repurposed drugs such as hydroxychloroquine (HCQ), azithromycin, lopinavir/ritonavir, and favipiravir with QT interval prolongation in patients with SARS-CoV2 infection. Little is known about the risk fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::495ee7c8b9c7046181baa3ce20563803
https://www.repository.cam.ac.uk/handle/1810/333187
https://www.repository.cam.ac.uk/handle/1810/333187
Publikováno v:
Progress in Pediatric Cardiology. 66:101547
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79258cca103c011478e86f36d2e2be54
https://doi.org/10.1016/j.ppedcard.2022.101547
https://doi.org/10.1016/j.ppedcard.2022.101547
Autor:
Khalid Almuti, Yi Heng Li, Jun Jiang, David K.L. Quek, Chun Chieh Wang, Rong Bai, Noppacharn Uaprasert, Jamshed Dalal, Jack W.C. Tan, Koji Hasegawa, Swee Chong Seow, Christopher J. Hammett, Sidney Lo, Lai Heng Lee, Felicita Andreotti, Daniel T.T. Chong, Peter Verhamme, Rungroj Krittayaphong, Young Keun On, Sofian Johar
Publikováno v:
European Cardiology Review
European Cardiology Review, Vol 16, Iss, Pp-(2021)
European Cardiology Review, Vol 16, Iss, Pp-(2021)
The disease burden of AF is greater in Asia-Pacific than other areas of the world. Direct oral anticoagulants (DOACs) have emerged as effective alternatives to vitamin K antagonists (VKA) for preventing thromboembolic events in patients with AF. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f73a6b3cd2041d77a2e596b48353c22f
https://doi.org/10.15420/ecr.2020.43
https://doi.org/10.15420/ecr.2020.43
Autor:
Leen Oyoun Alsoud, Khalid Almuti, Wasim S El Nekidy, Mohamed AlJaabari, Wael Al Mahmeed, Bassam Atallah, Zohour Anouassi
Publikováno v:
Journal of cardiovascular pharmacology. 77(2)
Direct oral anticoagulants (DOACs) have proven efficacy to prevent cardioembolic strokes. Data are scarce about the appropriateness of DOAC dosing in the Middle East. We investigated the prevalence of inappropriate DOAC dosing in the region. A cross-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15f88544f62404ff1d20706967f5132f
https://pubmed.ncbi.nlm.nih.gov/32925474
https://pubmed.ncbi.nlm.nih.gov/32925474
Autor:
Nils A. Guttenplan, Gia Tran, Bryan Meldrum, Asma Aouthmany, Bernadette Sheeron, Allan M. Greenspan, Agustina Saenz, Jessica Smukler, Sumeet K. Mainigi, Vincent M. Figueredo, Khalid Almuti
Publikováno v:
The American Journal of Cardiology. 109:231-237
Inappropriate implantable cardioverter-defibrillator (ICD) therapies can lead to significant adverse events and increased mortality. These therapies are often the result of supraventricular tachycardias (SVTs). The objective of this study was to eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f993cd65a6df2ed62a8e1e976b881dc
https://doi.org/10.1016/j.amjcard.2011.08.035
https://doi.org/10.1016/j.amjcard.2011.08.035
Publikováno v:
Journal of the American Society of Echocardiography. 21:34-37
Practice guidelines of the American College of Cardiology (ACC) and the American Heart Association (AHA) define aortic stenosis (AS) as being severe when the aortic valve area (AVA) is less than or equal to 1.0 cm and as moderate when the AVA is grea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::949d8106ec89701afd31b362bd835b9e
https://doi.org/10.1016/j.echo.2007.04.031
https://doi.org/10.1016/j.echo.2007.04.031
Publikováno v:
Management of Cardiac Arrhythmias ISBN: 9781607611608
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::941804c90679ed156764db7dce381f7f
https://doi.org/10.1007/978-1-60761-161-5_7
https://doi.org/10.1007/978-1-60761-161-5_7
Autor:
Belda-Hofheinz, Sylvia
Publikováno v:
Critical Care Medicine; Sep2023, Vol. 51 Issue 9, p1264-1267, 4p